Neumora Therapeutics, Inc.'s total assets for Q4 2025 were $191.05M, an increase of 7.43% from the previous quarter. NMRA total liabilities were $87.18M for the fiscal quarter, a 90.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.